{"tid":1891956,"cid":5,"subCid":0,"title":"「瑞德西韋」藥廠原則上同意本港加入臨床試驗","createTime":"2020-02-22T08:13:29.000Z","updateTime":"2020-02-22T08:23:21.000Z","uid":177168,"like":2,"dislike":0,"uniUserReply":4,"replies":[{"pid":"9d6ac946bd32e7d9a64dcbb9395b76f1a899d45a","tid":1891956,"uid":177168,"like":0,"dislike":0,"score":0,"citedBy":0,"replyTime":"2020-02-22T08:13:29.000Z","msg":"美國藥廠吉利德科學公司開發的藥物「瑞德西韋」（Remdesivir），有望成為治療新型冠狀病毒的針對性藥物。該藥即將於內地開展臨床試驗，據悉，藥廠原則上同意香港加入亞洲區臨床試驗。亞洲區臨床試驗料有數百個名額，南韓及新加坡可能會參加；可參加臨床試驗的香港病人數目，視乎香港未來有多少確診病人，及病人是否符合藥廠的用藥準則，有關準則獲美國疾控中心批准。<br />\n<br />\n<a href=\"https://hk.news.appledaily.com/local/20200222/A4WEQEWWJO5UQ64SOCVD2YLGW4/\" data-sr-url=\"https://r.lihkg.com/link?u=https%3A%2F%2Fhk.news.appledaily.com%2Flocal%2F20200222%2FA4WEQEWWJO5UQ64SOCVD2YLGW4%2F&d=tV%2Fsyqxl7HZnCfU9ck6AAGSJzKb80PJXVuqujnuB1ho%3D&h=cb5aaebb\" data-ef-url=\"https://embed.lih.kg/frame?u=https%3A%2F%2Fhk.news.appledaily.com%2Flocal%2F20200222%2FA4WEQEWWJO5UQ64SOCVD2YLGW4%2F&h=58a8358e\" target=\"_blank\">https://hk.news.appledaily.com/local/20200222/A4WEQEWWJO5UQ64SOCVD2YLGW4/</a>"},{"pid":"e869c459b7d575c14f5b1054913db8499efec709","tid":1891956,"uid":303304,"like":0,"dislike":0,"score":0,"citedBy":0,"replyTime":"2020-02-22T08:14:50.000Z","msg":"［奶共美國公司］IG(facebook)奶共維穩證據<br />\n<a href=\"https://lih.kg/1891917\" data-auto-link target=\"_blank\">https://lih.kg/1891917</a><br />\n- 分享自 LIHKG 討論區"},{"pid":"ce5fde202e70688a22a8d4ab319898a9c77122c7","tid":1891956,"uid":68541,"like":0,"dislike":0,"score":0,"citedBy":0,"replyTime":"2020-02-22T08:21:46.000Z","msg":"<img src=\"/assets/faces/mouse/please.gif\" class=\"hkgmoji\" /><img src=\"/assets/faces/mouse/please.gif\" class=\"hkgmoji\" /><img src=\"/assets/faces/mouse/please.gif\" class=\"hkgmoji\" />"},{"pid":"70a53feaa1b5af0202ed9104d2cb1fcd9e138bc0","tid":1891956,"uid":298115,"like":0,"dislike":0,"score":0,"citedBy":0,"replyTime":"2020-02-22T08:23:21.000Z","msg":"此回覆已被刪除"}]}